Literature DB >> 21705410

The association between variants on chromosome 9p21 and inflammatory biomarkers in ethnically diverse women with coronary heart disease: a pilot study.

Theresa M Beckie1, Jason W Beckstead, Maureen W Groer.   

Abstract

BACKGROUND: The most consistently replicated genetic variants associated with coronary heart disease (CHD) in populations of European descent have been found on chromosome 9p21. Yet there is little known about these associations in ethnic groups of African ancestry. These disease-associated variants are located in a genomic region of unknown function. The purpose of this exploratory study was to examine the allelic frequencies and haplotype structure of single nucleotide polymorphisms (SNPs) for Black and White women with CHD. The authors also sought to explore the relationship between these genetic variants and biomarkers of inflammation.
METHODS: Using polymerase chain reaction amplification, the authors genotyped 8 SNPs in a 58-kilobase region of chromosome 9p21 in a cohort of women with CHD (n = 91). The authors examined the interethnic relationship between the SNPs and four inflammatory biomarkers (C-reactive protein, intercellular adhesion molecule-1, interleukin-6, and tumor necrosis factor-alpha) using analysis of variance (ANOVA).
RESULTS: We found considerable interethnic allelic and haplotype diversity across the 9p21 locus, with only two SNPs in perfect linkage disequilibrium (LD) in both races. A pair of high- and low-risk haplotypes was most common in White women, while about 41% of Blacks carried the risk alleles for three of the eight SNPs the authors examined. The interethnic associations between the SNP genotypes and inflammatory markers were divergent in both direction and magnitude.
CONCLUSIONS: Our results lend support for the importance of ancestry-specific allelic context when examining variants on chromosome 9p21. Additional work is needed to elucidate the genetic contribution to inflammatory biomarkers for diverse racial groups.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705410      PMCID: PMC4118425          DOI: 10.1177/1099800411403469

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  74 in total

Review 1.  More than obvious: better methods for interpreting nondetect data.

Authors:  Dennis R Helsel
Journal:  Environ Sci Technol       Date:  2005-10-15       Impact factor: 9.028

2.  Multimarker prediction of coronary heart disease risk: the Women's Health Initiative.

Authors:  Hyeon Chang Kim; Philip Greenland; Jacques E Rossouw; JoAnn E Manson; Barbara B Cochrane; Norman L Lasser; Marian C Limacher; Donald M Lloyd-Jones; Karen L Margolis; Jennifer G Robinson
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

3.  A common variant at 9p21 is associated with sudden and arrhythmic cardiac death.

Authors:  Christopher Newton-Cheh; Nancy R Cook; Martin VanDenburgh; Eric B Rimm; Paul M Ridker; Christine M Albert
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

4.  The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.

Authors:  Theresa M Beckie; Jason W Beckstead; Maureen W Groer
Journal:  J Cardiovasc Nurs       Date:  2010 Jan-Feb       Impact factor: 2.083

5.  Molecular genetics of myocardial infarction.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Genomic Med       Date:  2008-08-14

6.  Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study.

Authors:  Themistocles L Assimes; Joshua W Knowles; Analabha Basu; Carlos Iribarren; Audrey Southwick; Hua Tang; Devin Absher; Jun Li; Joan M Fair; Geoffrey D Rubin; Stephen Sidney; Stephen P Fortmann; Alan S Go; Mark A Hlatky; Richard M Myers; Neil Risch; Thomas Quertermous
Journal:  Hum Mol Genet       Date:  2008-04-28       Impact factor: 6.150

7.  Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis.

Authors:  Nilesh J Samani; Olli T Raitakari; Kalle Sipilä; Martin D Tobin; Heribert Schunkert; Markus Juonala; Peter S Braund; Jeanette Erdmann; Jorma Viikari; Leena Moilanen; Leena Taittonen; Antti Jula; Eero Jokinen; Tomi Laitinen; Nina Hutri-Kähönen; Markku S Nieminen; Y Antero Kesäniemi; Alistair S Hall; Janne Hulkkonen; Mika Kähönen; Terho Lehtimäki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-03       Impact factor: 8.311

8.  Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.

Authors:  Tobias Pischon; Frank B Hu; Kathryn M Rexrode; Cynthia J Girman; Joann E Manson; Eric B Rimm
Journal:  Atherosclerosis       Date:  2007-08-02       Impact factor: 5.162

9.  Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial.

Authors:  Theresa M Beckie; Mary Ann Mendonca; Gerald F Fletcher; Douglas D Schocken; Mary E Evans; Steven M Banks
Journal:  J Cardiopulm Rehabil Prev       Date:  2009 Jan-Feb       Impact factor: 2.081

10.  Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease.

Authors:  Kaisa Silander; Hua Tang; Sean Myles; Eveliina Jakkula; Nicholas J Timpson; Luigi Cavalli-Sforza; Leena Peltonen
Journal:  Genome Med       Date:  2009-05-12       Impact factor: 11.117

View more
  6 in total

Review 1.  Genetics of coronary artery disease: an update.

Authors:  Robert Roberts
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

2.  Biopsychosocial health disparities among young women enrolled in cardiac rehabilitation.

Authors:  Theresa M Beckie; Gerald Fletcher; Maureen W Groer; Kevin E Kip; Ming Ji
Journal:  J Cardiopulm Rehabil Prev       Date:  2015 Mar-Apr       Impact factor: 2.081

3.  "Desert" gene (Chr9p21) variants as novel markers for coronary artery disease.

Authors:  Heba A Shendy; Sally I Hassanein; Mohamed Z Gad
Journal:  Anatol J Cardiol       Date:  2017-05-30       Impact factor: 1.596

4.  PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.

Authors:  Pavel Hamet; Mounsif Haloui; François Harvey; François-Christophe Marois-Blanchet; Marie-Pierre Sylvestre; Muhammad-Ramzan Tahir; Paul H G Simon; Beatriz Sonja Kanzki; John Raelson; Carole Long; John Chalmers; Mark Woodward; Michel Marre; Stephen Harrap; Johanne Tremblay
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

5.  Genetic variation in 9p21 is associated with fasting insulin in women but not men.

Authors:  Sara Mahdavi; David J A Jenkins; Ahmed El-Sohemy
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

6.  High shear stress enhances endothelial permeability in the presence of the risk haplotype at 9p21.3.

Authors:  Evan L Teng; Evan M Masutani; Benjamin Yeoman; Jessica Fung; Rachel Lian; Brenda Ngo; Aditya Kumar; Jesse K Placone; Valentina Lo Sardo; Adam J Engler
Journal:  APL Bioeng       Date:  2021-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.